Antimicrobial prescribing: meropenem with vaborbactam
National Institute of Health and Care Excellence ,
Key messages The content of this evidence review was up-to-date in November 2019.
Key messages The content of this evidence review was up-to-date in November 2019.
– The Menarini Group has recently reached an agreement with Melinta Therapeutics to commercialize meropenem/vaborbactam in…
/PRNewswire/ -- Autorisation le 20 novembre 2018 par la Commission européenne du méropénème/vaborbactam pour un usage clinique…
/PRNewswire/ -- Meropenem/Vaborbactam wurde am 20. November 2018 von der EU-Kommission für den klinischen Einsatz bei…
/PRNewswire/ -- Related Biotechnology, Pharmaceutical and Healthcare News Meropenem/vaborbactam approved on 20th November 2018…
-- Meropenem/vaborbactam, 치료가 어려운 성인 전염병 환자에 대한 임상용으로 2018년 11월 20일 유럽 위원회로부터 승인 획득 -- 유럽에서 임상용으로 승인받은 최초의 carbapenem과 베타 락타마아제 억…
FLORENCIA, Italia, December 11, 2018 /PRNewswire/ -- -- Meropenem/vaborbactam fue aprobado el 20 de noviembre de 2018 por la…
/PRNewswire/ -- • Meropenem/vaborbactam fue aprobado el 20 de noviembre de 2018 por la Comisión Europea para uso clínico en…
/PRNewswire/ -- -- Meropenem/vaborbactam fue aprobado el 20 de noviembre de 2018 por la Comisión Europea para uso clínico en…
- The Menarini Group has recently reached an agreement with Melinta Therapeutics to commercialize meropenem/vaborbactam in…
De-colonization of therapy dogs lessens risk of MRSA spread, study finds A pilot study conducted by researchers at Johns…
Combo antibiotic for CRE infections performs well in phase 3 trial The results of a phase 3 randomized, controlled clinical…
GlobeNewswire 2018-10-02 Vabomere monotherapy was associated with increased clinical cure, decreased mortality, and was well…
Vabomere monotherapy was associated with increased clinical cure, decreased mortality, and was well tolerated compared to best…
Vabomere monotherapy was associated with increased clinical cure, decreased mortality, and was well tolerated compared to best…